Shionogi & Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Cost-of-Goods-Sold-Including-Depreciation-and-Amortization" stands at 63.69 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025.
Shionogi & Co. Ltd.'s first quarter result of 12.32 Billion JPY for the item "Cost of Goods Sold Including Depreciation and Amortization" represents a decrease of -34.18 percent compared to it's fourth quarter result of the company's last fiscal year.
Also, Shionogi & Co. Ltd.'s first quarter result of 12.32 Billion JPY for the item "Cost of Goods Sold Including Depreciation and Amortization" represents a decrease of -14.71 percent compared to it's first quarter result of last year.
Looking again at the trailing twelve months series (TTM), Shionogi & Co. Ltd.'s first quarter result of 63.69 Billion JPY for the item "Cost of Goods Sold Including Depreciation and Amortization" represents a decrease of -3.23 percent compared to it's fourth quarter result of the company's last fiscal year.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 6.11 percent compared to the value the year prior.
The 1 year change in percent is 6.11.
The 3 year change in percent is 13.68.
The 5 year change in percent is 15.13.
The 10 year change in percent is -20.78.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Cost of Goods Sold Including Depreciation and Amortization | 905,699,262,464.00 |
![]() | Johnson & Johnson - Cost of Goods Sold Including Depreciation and Amortization | 486,508,953,600.00 |
![]() | AbbVie Inc - Cost of Goods Sold Including Depreciation and Amortization | 399,570,305,024.00 |
![]() | Roche Holding AG - Cost of Goods Sold Including Depreciation and Amortization | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Cost of Goods Sold Including Depreciation and Amortization | 280,205,508,085.11 |